Department of Medical and Clinical Psychology, CoRPS - Center of Research on Psychology in Somatic Diseases, Tilburg University, Warandelaan 2, PO Box 90153, 5000 LE, Tilburg, The Netherlands.
The Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
Qual Life Res. 2018 Dec;27(12):3313-3324. doi: 10.1007/s11136-018-1979-0. Epub 2018 Aug 30.
The 'Patient Reported Outcomes Following Initial treatment and Long-term Evaluation of Survivorship' (PROFILES) registry collects patient-reported outcomes (PROs) from short- and long-term cancer survivors in the Netherlands, in a population-based setting. The aim of this analysis is to assess the generalizability of observational PRO research among cancer survivors by comparing socio-demographic and clinical characteristics, and survival of participants and non-participants in cancer survivors invited for questionnaire research through the PROFILES registry.
Between 2008 and 2015, cancer survivors with different cancer diagnoses (N = 14,011) were invited to participate in PROFILES registry studies, of whom 69% (N = 9684) participated. Socio-demographic and clinical characteristics and survival data, collected through the Netherlands Cancer Registry, were associated with participation versus non-participation in multivariable logistic regression analyses and cox proportional hazard regression models, respectively.
Participants had a significantly better survival compared to non-participants (HR = 1.47, P < .01). Participation was associated with male gender, being 60-70 years old, high socio-economic status, receiving any treatment, receiving radiotherapy, having no comorbidities, and a cancer diagnosis 2-3 years before invitation. Sensitivity analysis demonstrates that the health-related quality of life (HRQoL) might be up to 1.3 points lower (scale 0-100) using hot deck imputation compared to non-imputed participant data.
Cancer survivors not participating in observational PROs research significantly differ from participants, with respect to socio-demographic and clinical characteristics, and survival. Their HRQoL scores may be systematically lower compared to participants. Therefore, even in PRO studies with relatively high participation rates, observed outcomes may represent the healthier patient with better outcomes.
“初始治疗和生存长期评估后患者报告结局”(PROFILES)登记处从荷兰基于人群的环境中收集短期和长期癌症幸存者的患者报告结局(PRO)。本分析的目的是通过比较受邀参加 PROFILES 登记处问卷研究的癌症幸存者的参与者和非参与者的社会人口统计学和临床特征以及生存情况,评估观察性 PRO 研究的普遍性。
2008 年至 2015 年期间,邀请患有不同癌症诊断的癌症幸存者(N=14011)参加 PROFILES 登记处研究,其中 69%(N=9684)参加。通过荷兰癌症登记处收集社会人口统计学和临床特征以及生存数据,将其与多变量逻辑回归分析和 Cox 比例风险回归模型中的参与与非参与相关联。
与非参与者相比,参与者的生存率显著提高(HR=1.47,P<.01)。参与与男性、60-70 岁、高社会经济地位、接受任何治疗、接受放疗、无合并症以及邀请前 2-3 年的癌症诊断相关。敏感性分析表明,与未进行参与者数据插补相比,使用热deck 插补,健康相关生活质量(HRQoL)的得分可能低 1.3 分(0-100 分量表)。
未参与观察性 PRO 研究的癌症幸存者在社会人口统计学和临床特征以及生存方面与参与者存在显著差异。与参与者相比,他们的 HRQoL 评分可能系统地更低。因此,即使在参与率相对较高的 PRO 研究中,观察到的结果也可能代表具有更好结局的更健康的患者。